Private equity firm Carlyle partners with Viyash Life Sciences for pharma platform
Viyash has ten manufacturing facilities in India with a combined capacity of 2000 KL as well as one formulation facility in the US, and is now one of India’s leading mid-tier integrated API and formulation players